TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling

Journal of Cell Science

Volumn 110, Issue 15, 1997, Pages 1741-1750

  Zinszner, Helene ^a   Sok, John ^a   Immanuel, David ^a   Yin, Yin ^a   Ron, David ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Monoclonal antibody; Nuclear localization; Sarcoma; Transcription

Indexed keywords

ANTIBODY; CHAPERONE; GENE PRODUCT; HYBRID PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; RIBONUCLEOPROTEIN; RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FRACTIONATION; CELL NUCLEUS; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOPLASM; HELA CELL; HETEROKARYON; HUMAN; HUMAN CELL; LEUKEMIA; LIPOSARCOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN RNA BINDING; RNA TRANSPORT; SARCOMA; ULTRAVIOLET RADIATION; XENOPUS;

ANIMALS; CELL NUCLEUS; CENTRIFUGATION, DENSITY GRADIENT; COCULTURE TECHNIQUES; COS CELLS; CYTOPLASM; DACTINOMYCIN; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MICE; NUCLEIC ACID SYNTHESIS INHIBITORS; RIBONUCLEOPROTEINS; RNA; RNA-BINDING PROTEIN FUS; RNA-BINDING PROTEINS; ULTRAVIOLET RAYS; XENOPUS;

ANIMALIA;

EID: 0030746523     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Barone, M. V., Crozat, A. Y., Tabaee, A., Philipson, L. and Ron, D. (1994). CHOP (GADD153) and its oncogenic variant, TLS-CHOP, differ in their ability to induce G1/S arrest. Genes Dev. 8, 453-464.
2. Bertolotti, A., Lutz, Y., Heard, D., Chambon, P. and Tora, L. (1996). hTAFII68, a novel RNA/ssDNA-binding protein with homology to the prooncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 15, 5022-5031.
3. Blau, H. (1989). How fixed is the differentiated state. Trends Genet. 5, 268-272.
4. Borer, R., Lehner, C., Eppenberger, H. and Nigg, E. (1989). Major nucleolar proteins shuttle between the nucleus and cytoplasm. Cell 56, 379-390.
5. Burd, C. and Dreyfuss, G. (1994). Conserved structures and diversity of functions of RNA-binding proteins. Science 265, 615-621.
6. Calvio, C. and Lamond, A. (1995). Identification of hnRNP P2 as TLS/FUS using electrospray mass spectrometry. RNA 1, 724-733.
7. Crozat, A. Y., Åman, P., Mandahl, N. and Ron, D. (1993). Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma with t(12;16)(q13:p11). Nature 363, 640-644.
8. Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., deJong, P., Rouleau, G., Aurias, A. and Thomas, G. (1992). Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359, 162-165.
9. Dreyfuss, G., Adam, S. A. and Choi, Y. D. (1984). Physical changes in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription. Mol. Cell. Biol. 4, 415-423.
10. Economidis, I. and Pederson, T. (1983). Structure of nuclear ribonucleoprotein: heterogenous nuclear RNA is complexed with a major sextet of proteins in vivo. Proc. Nat. Acad. Sci. USA 80, 1599-1602.
11. Haynes, S. R. (1992). The RNP motif protein family. New Biol. 4, 421-429.
12. Immanuel, D., Zinszner, H. and Ron, D. (1995). Association of SARFH (sarcoma associated RNA-binding fly homologue), with regions of chromatin transcribed by RNA polymerase II. Mol. Cell. Biol. 15, 4562-4571.
13. Kenan, D. J., Query, C. C. and Keene, J. D. (1991). RNA recognition: towards identifying determinants of specificity. Trends Biochem. Sci. 16. 214-220.
14. Matunis, E. L., Matunis, M. J. and Dreyfuss, G. (1992). Drosophila heterogenous nuclear ribonucleoproteins. J. Cell Biol. 116, 257-269.
15. May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G. and Denny, C. T. (1993a). Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Nat. Acad. Sci. USA 90, 5752-5756.
16. May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R. and Denny, C. T. (1993b). The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13, 7393-7398.
17. McCracken, S., Fong, N., Yankulov, K., Ballantyne, S., Pan, G., Greenblatt, J., Patterson, S., Wickens, M. and Bently, D. (1997). The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385, 357-361.
18. Michael, W., Choi, M. and Dreyfuss, G. (1995). A nuclear export signal in hnRNP A1: A signal mediated, temperature-dependent nuclear protein export pathway. Cell 83, 415-422.
19. Ohno, T., Ouchida, M., Lee, L., Gatalica, Z., Rao, V. and Reddy, E. (1994). The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round tumors, codes for an RNA binding proteins with novel regulatory domains. Oncogene 9, 3087-3097.
20. Pinol-Roma, S. and Dreyfuss, G. (1992). Shuttling of pre-mRNA binding proteins between the nucleus and cytoplasm. Nature 355, 730-732.
21. Pinol-Roma, S. and Dreyfuss, G. (1993). hnRNP proteins: localization and transport between the nucleus and the cytoplasm. Trends Cell Biol 3 151-155.
22. Prasad, D., Ouchida, M., Lee, L., Rao, V. N. and Reddy, E. (1994) TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16:21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9, 3717-3729.
23. Rabbitts, T. H. (1994). Chromosomal translocations in human cancer. Nature 372, 143-149.
24. Ron, D. (1996). TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation. In Chromosomal Translocations and Oncogenic Transcription Factors (ed. P. Vogt and F. Rauscher), pp. 131-142. Springer-Verlag, Berlin.
25. Sanchez-Garciá, I. and Rabbitts, T. (1994). Transcriptional activation by TAL1 und FUS-CHOP proteins expressed in acute malignancies as a result of chrmosomal abnormalities. Proc. Nat. Acad. Sci. USA 91, 7869-7873.
26. Schreiber, E., Matthias, P., Muller, M. M. and Schaffner, W. (1989). Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucl. Acids Res. 17, 6419.
27. Stolow, D. and Haynes, S. (1995). Cabeza, a Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. Nucl. Acids Res. 23, 835-843.
28. van Eckelen, C., Buijtels, H., Linné, T., Ohlsson, R., Philipson, L. and van Venrooij, W. (1982). Detection of a cellular polypeptide associated with adenovirus-coded VA RNA using in vitro labeling of proteins cross-linked to RNA. Nucl. Acid Res. 10, 3039-3052.
29. Visa, N., Alzhanova-Ericsson, A., Sun, X., Kiseleva, E., Björkroth, B., Wurtz, T. and Daneholt, B. (1996). A pre-mRNA-binding protein accompanies the RNA from the gene through the nuclear pores and into polysomes. Cell 84, 253-264.
30. Wagenmakers, A., Reinders, R. and Van Venrooij, W. (1980). Cross-linking of mRNA to proteins by irradiation of intact cells with ultraviolet light. Eur. J. Biochem. 112, 323-330.
31. Zinszner, H., Albalat, R. and Ron, D. (1994). A novel effector domain from the RNA-binding proteins TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 8, 2513-2526.
32. Zinszner, H., Immanuel, D., Yin, Y., Liang, F.-X. and Ron, D. (1997). A topogenic role for the N terminus of TLS: nucleolar localization when transcription is inhibited. Oncogene 14, 451-461.